Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Salvage Surgery After Chemoradiotherapy in the Management of Esophageal Cancer: Is It a Viable Therapeutic Option?

Markar S, Gronnier C, Duhamel A, Pasquer A, Théreaux J, du Rieu MC, Lefevre JH, Turner K, Luc G, Mariette C.

J Clin Oncol. 2015 Nov 20;33(33):3866-73. doi: 10.1200/JCO.2014.59.9092. Epub 2015 Jul 20.

PMID:
26195702
2.

Systematic review and meta-analysis on the significance of salvage esophagectomy for persistent or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy.

Kumagai K, Mariosa D, Tsai JA, Nilsson M, Ye W, Lundell L, Rouvelas I.

Dis Esophagus. 2016 Oct;29(7):734-739. doi: 10.1111/dote.12399. Epub 2015 Aug 28. Review.

PMID:
26316181
3.

Sex Disparities After Induction Chemoradiotherapy and Esophagogastrectomy for Esophageal Cancer.

Rowse PG, Jaroszewski DE, Thomas M, Harold K, Harmsen WS, Shen KR.

Ann Thorac Surg. 2017 Oct;104(4):1147-1152. doi: 10.1016/j.athoracsur.2017.05.030. Epub 2017 Aug 22.

PMID:
28842111
4.

Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.

Tapias LF, Mathisen DJ, Wright CD, Wain JC, Gaissert HA, Muniappan A, Lanuti M, Donahue DM, Morse CR.

Ann Thorac Surg. 2016 Mar;101(3):1097-103. doi: 10.1016/j.athoracsur.2015.09.062. Epub 2015 Dec 1.

PMID:
26652140
5.

Salvage esophagectomy after failed definitive chemoradiation for esophageal adenocarcinoma.

Marks JL, Hofstetter W, Correa AM, Mehran RJ, Rice D, Roth J, Walsh G, Vaporciyan A, Erasmus J, Chang J, Maru D, Lee JH, Lee J, Ajani JA, Swisher SG.

Ann Thorac Surg. 2012 Oct;94(4):1126-32; discussion 1132-3. doi: 10.1016/j.athoracsur.2012.05.106. Epub 2012 Aug 24.

PMID:
22921233
6.

Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.

Naik KB, Liu Y, Goodman M, Gillespie TW, Pickens A, Force SD, Steuer CE, Owonikoko TK, Ramalingam SS, Higgins K, Beitler JJ, Shin DM, Willingham FF, El-Rayes B, Landry JC, Fernandez FG, Saba NF.

Cancer. 2017 Sep 15;123(18):3476-3485. doi: 10.1002/cncr.30763. Epub 2017 May 2.

7.

[Salvage surgery in esophageal cancer : Feasibility in patients after definitive radiochemotherapy (> 50 Gy)].

Schmidt T, Sisic L, Sterzing F, Haag GM, Kunzmann R, Grenacher L, Weichert W, Jäger D, Büchler MW, Ott K.

Chirurg. 2015 Oct;86(10):955-62. doi: 10.1007/s00104-014-2971-z. German.

PMID:
25715974
8.

Role of neoadjuvant treatment in clinical T2N0M0 oesophageal cancer: results from a retrospective multi-center European study.

Markar SR, Gronnier C, Pasquer A, Duhamel A, Beal H, Théreaux J, Gagnière J, Lebreton G, Brigand C, Meunier B, Collet D, Mariette C; FREGAT working group – FRENCH – AFC.

Eur J Cancer. 2016 Mar;56:59-68. doi: 10.1016/j.ejca.2015.11.024. Epub 2016 Jan 23.

PMID:
26808298
9.

Assessment of short-term clinical outcomes following salvage esophagectomy for the treatment of esophageal malignancy: systematic review and pooled analysis.

Markar SR, Karthikesalingam A, Penna M, Low DE.

Ann Surg Oncol. 2014 Mar;21(3):922-31. doi: 10.1245/s10434-013-3364-0. Epub 2013 Nov 9. Review.

PMID:
24212722
10.

Salvage esophagectomy in the management of recurrent or persistent esophageal carcinoma.

Marks J, Rice DC, Swisher SG.

Thorac Surg Clin. 2013 Nov;23(4):559-67. doi: 10.1016/j.thorsurg.2013.08.001. Review.

PMID:
24199705
11.

Salvage Esophagectomy After Definitive Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Who Really Benefits from this High-Risk Surgery?

Watanabe M, Mine S, Nishida K, Yamada K, Shigaki H, Matsumoto A, Sano T.

Ann Surg Oncol. 2015 Dec;22(13):4438-44. doi: 10.1245/s10434-015-4556-6. Epub 2015 Apr 11.

PMID:
25862582
12.

Survival Benefit of Neoadjuvant Treatment in Clinical T3N0M0 Esophageal Cancer: Results From a Retrospective Multicenter European Study.

Mantziari S, Gronnier C, Renaud F, Duhamel A, Théreaux J, Brigand C, Carrère N, Lefevre JH, Pasquer A, Demartines N, Collet D, Meunier B, Mariette C; FREGAT working group – FRENCH – AFC.

Ann Surg. 2017 Nov;266(5):805-813. doi: 10.1097/SLA.0000000000002402.

PMID:
28742698
13.

Salvage esophagectomy for locoregional failure after chemoradiotherapy in patients with advanced esophageal cancer.

Yoo C, Park JH, Yoon DH, Park SI, Kim HR, Kim JH, Jung HY, Lee GH, Choi KD, Song HJ, Song HY, Shin JH, Cho KJ, Kim YH, Kim SB.

Ann Thorac Surg. 2012 Dec;94(6):1862-8. doi: 10.1016/j.athoracsur.2012.07.042. Epub 2012 Sep 7.

PMID:
22959577
14.

Evolution of standardized clinical pathways: refining multidisciplinary care and process to improve outcomes of the surgical treatment of esophageal cancer.

Markar SR, Schmidt H, Kunz S, Bodnar A, Hubka M, Low DE.

J Gastrointest Surg. 2014 Jul;18(7):1238-46. doi: 10.1007/s11605-014-2520-6. Epub 2014 Apr 29.

PMID:
24777435
15.

Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma.

Rice TW, Adelstein DJ, Chidel MA, Rybicki LA, DeCamp MM, Murthy SC, Blackstone EH.

J Thorac Cardiovasc Surg. 2003 Nov;126(5):1590-6.

16.

Esophagectomy Timing After Neoadjuvant Therapy for Distal Esophageal Adenocarcinoma.

Franko J, Voynov G, Goldman CD.

Ann Thorac Surg. 2016 Mar;101(3):1123-30. doi: 10.1016/j.athoracsur.2015.09.044. Epub 2015 Dec 1.

PMID:
26652139
17.

Salvage esophagectomy after failure of definitive radiochemotherapy for esophageal cancer.

Farinella E, Safar A, Nasser HA, Bouazza F, Liberale G, Paesmans M, Marechal R, Van Laethem JL, Hendlisz A, VanHoutte P, El Nakadi I.

J Surg Oncol. 2016 Dec;114(7):833-837. doi: 10.1002/jso.24429. Epub 2016 Oct 25.

PMID:
27778349
18.

A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246.

Swisher SG, Winter KA, Komaki RU, Ajani JA, Wu TT, Hofstetter WL, Konski AA, Willett CG.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1967-72. doi: 10.1016/j.ijrobp.2011.01.043. Epub 2011 Apr 18.

19.

Curative treatment for esophageal cancer: Vancouver Island Cancer Centre experience from 1993 to 1998.

Wilson KS, Wilson AG, Dewar GJ.

Can J Gastroenterol. 2002 Jun;16(6):361-8.

PMID:
12096299
20.

Different recurrence pattern after neoadjuvant chemoradiotherapy compared to surgery alone in esophageal cancer patients.

Smit JK, Güler S, Beukema JC, Mul VE, Burgerhof JG, Hospers GA, Plukker JT.

Ann Surg Oncol. 2013 Nov;20(12):4008-15. doi: 10.1245/s10434-013-3102-7. Epub 2013 Jul 10.

PMID:
23838922

Supplemental Content

Support Center